Skip to content

Real-World Observational Study on Chinese Herbal Medicine for Managing Post-Chikungunya Chronic Arthralgia

Real-World Observational Study on Chinese Herbal Medicine for Managing Post-Chikungunya Chronic Arthralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001732
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Chikungunya Chronic Arthralgia

Interventions

Traditional Chinese Medicine cohort: The prescription for Post-Chikungunya Chronic Arthralgia (5g of cinnamon twig, 15g of Niudili, 15g of wide-tendon vine, 10g of Zouma Tai, 10g of Haifeng Vine, 10g
Western medicine cohort:NSAIDs drugs are mainly used (celecoxib + diclofenac sodium patches), and other drugs and rehabilitation treatments should be avoided as much as possible.
Ultrasonic cohort:Only ultrasound treatment (10 times) is used, and the dosage should avoid other traditional Chinese medicine and Western medicine treatments
Blank control cohort:There are no treatment measures.

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria stipulated in the "Diagnosis and Treatment Plan for Chikungunya Fever (2025 Edition)"; 2. The course of the disease is more than one month; 3. The actual clinical prescription conforms to the medication regimen of the observation cohort. 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation period; 2. Joint pain is considered not to be caused by chikungunya fever. 3. Participated in other interventional clinical trials in the past three months; 4. Severe liver and kidney dysfunction (ALT/AST>2×ULN, or eGFR<30 ml/min); 5.Participants who were considered unsuitable for inclusion in the study by the researchers.

Design outcomes

Primary

MeasureTime frame
Joint Symptom Evaluation (RAPID3;

Secondary

MeasureTime frame
Score of the Traditional Chinese Medicine Syndrome Scale;Chikungunya fever antibody;Blood routine, urine routine, C-reactive protein, erythrocyte sedimentation rate, rheumatoid factor, liver function (Alanine Aminotransferase, Aspartate Aminotransferase, Creatinine, Blood Urea) Nitrogen, Myocardial enzyme spectrum (Creatine Kinase, Creatine kinase-myocardial Band, Lactate Dehydrogenase), hypersensitive troponin, coagulation function (Prothrombin Time, Activated Partial Thromboplastin Time, International Normalized Ratio, Fibrinogen);musculoskeletal B-ultrasound and Magnetic Resonance Imaging;

Countries

China

Contacts

Public ContactZheng Danwen

Guangdong Provincial Hospital of Traditional Chinese Medicine

36990981@qq.com+86 13631457177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026